moh ks management guidelines
DESCRIPTION
MOH KS management guidelines. Jane Bates Tiyanjane Clinic, QECH October 2009. Criteria for vincristine. Clinical diagnosis of KS. Tested for HIV. On ARVs for at least 3 months. advanced and / or progressive disease (check FBC) - consider vincristine. improving and / or stable disease - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: MOH KS management guidelines](https://reader036.vdocuments.site/reader036/viewer/2022082411/56812c68550346895d90ffe0/html5/thumbnails/1.jpg)
MOH KS management guidelines
Jane BatesTiyanjane Clinic, QECH
October 2009
![Page 2: MOH KS management guidelines](https://reader036.vdocuments.site/reader036/viewer/2022082411/56812c68550346895d90ffe0/html5/thumbnails/2.jpg)
Criteria for vincristine
Tested for HIV
advanced and / or progressive disease (check FBC)- consider vincristine
Clinical diagnosis of KS
On ARVs for at least 3 months
improving and / or stable disease - hold vincristine
High priority Medium Priority consider continue ARVSmay start before unilat or biilat. leg if exclusions 3 months ARVs completed KS limiting function apply confirmed or suspected oral lesions Pulmonary KS rapidly progressive maintain pain anddisease Involving face symptom control
![Page 3: MOH KS management guidelines](https://reader036.vdocuments.site/reader036/viewer/2022082411/56812c68550346895d90ffe0/html5/thumbnails/3.jpg)
ExclusionsAbsolute • severe peripheral neuropathy • unable to travel – financial or physical constraints• Hb < 8, platelet < 150• severe liver disturbance/diseaseRelative • near to another hospital site delivering
chemotherapy• minimal disease
![Page 4: MOH KS management guidelines](https://reader036.vdocuments.site/reader036/viewer/2022082411/56812c68550346895d90ffe0/html5/thumbnails/4.jpg)
2mg × six doses weeklySix week review If ‘no effect’, side effects and /or
limited stable disease - discontinueIf ‘good effect’, minimal side
effects and residual disease – continue
2mg × six doses fortnightly Review (as for six week review)2mg × six doses monthlyReview at end of schedule+ Review 3 months post treatment
Initial assessment visit
![Page 5: MOH KS management guidelines](https://reader036.vdocuments.site/reader036/viewer/2022082411/56812c68550346895d90ffe0/html5/thumbnails/5.jpg)
Pain and symptom control
• Assess and treat pain according to WHO analgesic ladder
• Salicylic acid cream/antihistamines for itching• Crushed metronidazole to reduce smell• potassium permanganate soaks to dry excess
oozing• Wound care, nutrition assessment and advice
![Page 6: MOH KS management guidelines](https://reader036.vdocuments.site/reader036/viewer/2022082411/56812c68550346895d90ffe0/html5/thumbnails/6.jpg)
WHO 3-stepLadder
1 mild1 mild
2 moderate2 moderate
3 severe3 severe
Morphine
± step 1 and/or Adjuvants
Morphine
± step 1 and/or Adjuvants
A/Codeine
A/Dihydrocodeine
Tramadol
± step 1 and/or Adjuvants
A/Codeine
A/Dihydrocodeine
Tramadol
± step 1 and/or Adjuvants
Aspirin
Paracetemol
NSAIDs
± Adjuvants
Aspirin
Paracetemol
NSAIDs
± Adjuvants
![Page 7: MOH KS management guidelines](https://reader036.vdocuments.site/reader036/viewer/2022082411/56812c68550346895d90ffe0/html5/thumbnails/7.jpg)
Drug type Drug name Dosage
(max daily dose)
Non opioids Paracetamol
Indomethacin
Aspirin
Brufen
1g qds (4g)
50mg tds (200mg)
300-900mg qds (4g)
400mg tds (2.4g)
Weak opioids Codeine
Dihydrocodeine
Compound preps
tramadol
30-60mg 4 hrly (240mg)
30mg 4-6 hrly (360mg)
2 tablets qds
50mg tds (400mg)
Strong opioids
Note : Pethidine is no longer recommended for treatment of chronic pain
Morphine Oral morphine solution, start at 2.5-5mg 4 hrly
MST, calculate according to need of oral solution (or start 10mg bd)
![Page 8: MOH KS management guidelines](https://reader036.vdocuments.site/reader036/viewer/2022082411/56812c68550346895d90ffe0/html5/thumbnails/8.jpg)
Other issues to consider
• This treatment regime is not curative• Patients/guardians need counselling about nature of
disease to assist with having realistic expectations• A major part of management is managing expectations
of patients, so information needs to be clear, consistent and honest
• At Tiyanjane we use a Chichewa information sheet for literate patients (double side A4) which you can have a copy of. If its of use photocopy and give out.
• If vincristine is not helping don’t continue it, aim for patient comfort and quality of life